Immune-mediated TTP Secondary to Checkpoint Inhibitor Use in a Patient with Stage IV Melanoma.
BMJ case reports(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined